Skip to content

Oliceridine versus Sufentanil: Effects on Postoperative Gastrointestinal Recovery in Elderly Patients after Lumbar Spine Surgery—A Prospective, Randomized, Double-Blind, Controlled Trial

Oliceridine versus Sufentanil: Effects on Postoperative Gastrointestinal Recovery in Elderly Patients after Lumbar Spine Surgery—A Prospective, Randomized, Double-Blind, Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123997
Enrollment
Unknown
Registered
2026-05-06
Start date
2026-05-06
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Control group:Sufentanyl for postoperative analgesia
Experimental group:Oliceridine for postoperative analgesia

Sponsors

The First Affiliated Hospital of Shihezi University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age between 60 and 80 years old 2. ASA grade I-III, without major systemic disease history 3. Body Mass Index (BMI) ranging from 18.5 to 28 kg/m^2 4. Elderly patients undergoing elective lumbar surgery under general anesthesia and sedation 5. Able to cooperate with perioperative sleep quality assessment and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery; 2. Long-term use of opioid drugs before the operation; 3. Previous history of schizophrenia, epilepsy, Parkinson's disease or myasthenia gravis; 4. Unable to communicate before the operation due to coma, severe dementia or language disorders; 5. Severe heart disease (Class 3 or above cardiac function), chronic obstructive pulmonary disease or pulmonary heart disease; 6. Severe liver function impairment (Child-Pugh grade C); 7. Severe kidney function impairment (requiring renal replacement therapy); 8. QT prolongation shown on the preoperative electrocardiogram; 9. History of gastrointestinal dysfunction before the operation; 10. Allergic to oxybenonium or other anesthetic drugs; 11. Asthmatic patients.

Design outcomes

Primary

MeasureTime frame
Measure the highest value of the I-FEED score continuously for four days after the surgery;

Secondary

MeasureTime frame
Ramsay score;Visual analogue pain rating;First deflation time, defecation time;The first time of tolerance for oral feeding;Postoperative hospital stay duration;

Countries

China

Contacts

Public ContactShi Chongzhi

The First Affiliated Hospital of Shihezi University

2237454056@qq.com+86 993 28586645

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026